Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse|
|Published species reactivity||Mouse, Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Human GLUT1 protein (between residues 1-100).|
|Purification||Antigen affinity chromatography|
|Storage buffer||tris glycine with 0.15M NaCl|
|Contains||0.05% sodium azide|
|Storage Conditions||-20°C or -80°C if preferred|
|Tested Applications||Dilution *|
|ChIP assay (ChIP)||Assay-Dependent|
|Flow Cytometry (Flow)||Assay-Dependent|
|Western Blot (WB)||0.5-2.0 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
The target sequence has 100% sequence homology with primate, and 93% with rat, bovine, and rabbit.
GLUT1 is a major glucose transporter in the mammalian blood brain barrier. It is ubiquitous, and is present at high levels in primate erythrocytes and brain endothelial cells. Glucose transporters are integral membrane glycoproteins involved in transporting glucose into most cells. There are seven types of glucose transport carrier proteins, designated as Glut 1 to 7.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
N-3PUFA differentially modulate palmitate-induced lipotoxicity through alterations of its metabolism in C2C12 muscle cells.
PA1-46152 was used in western blot to assess the effects of n-3PUFA on fatty acid metabolism and insulin sensitivity in muscle cells
|Pinel A,Rigaudière JP,Laillet B,Pouyet C,Malpuech-Brugère C,Prip-Buus C,Morio B,Capel F||Biochimica et biophysica acta (1861:12)||2016|
Metabolism modifications and apoptosis induction after Cellfood¿ administration to leukemia cell lines.
PA1-46152 was used in immunohistochemistry to study the mechanisms by which the nutritional supplement Cellfood impairs the viability of leukemia cell lines
|Catalani S,Carbonaro V,Palma F,Arshakyan M,Galati R,Nuvoli B,Battistelli S,Canestrari F,Benedetti S||Journal of experimental and clinical cancer research : CR (32:null)||2013|
choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity); DYT17; DYT18; Glucose transporter type 1, erythrocyte/brain; GLUT; GLUT-1; GLUT1; GT1; HepG2 glucose transporter; human T-cell leukemia virus (I and II) receptor; MGC141895; MGC141896; receptor for HTLV-1 and HTLV-2; solute carrier family 2 (facilitated glucose transporter), member 1; Solute carrier family 2, facilitated glucose transporter member 1; solute carrier family 2, member 1
CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; PED; SDCHCN; SLC2A1